CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

NOVARTIS AG

NVSEF
$269.02B
Mega Cap
NASDAQBiotechnology🇺🇸North America75.3K employees

Drugs in Pipeline

294

Phase 3 Programs

185

Upcoming Catalysts

10

Next Catalyst

Sep 2026

Market Overview

Stock performance and key metrics

NVSEF News
Catalyst Timeline

10 upcoming, 1 past

No catalysts found.

10 more catalysts beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro
Drug Pipeline

Bosutinib

Phase 3

Chronic Myelogenous Leukemia

Everolimus

Phase 3

Tuberous Sclerosis

Famciclovir

Phase 3

Herpes Labialis

Certoparin

Phase 3

Renal Dialysis

Inclisiran

Phase 3

Atherosclerotic Cardiovascular Disease

Alpelisib

Phase 3

Breast Neoplasms

Glimepiride

Phase 3

Type II Diabetes Mellitus

ACZ885

Phase 3

Pulmonary Sarcoidosis

asciminib

Phase 3

Chronic Myelogenous Leukemia - Chronic Phase

Everolimus (RAD001)

Phase 3

Renal Transplantation

Aflibercept

Phase 3

Diabetic Macular Edema

Salbutamol/albuterol

Phase 3

Chronic Obstructive Pulmonary Disease

Lansoprazole

Phase 3

Frequent Heartburn

Aliskiren/HCTZ

Phase 3

Hypertension

Pimecrolimus Cream 1%

Phase 3

Chronic Hand Dermatitis

Canakinumab 150 mg

Phase 3

Type 2 Diabetes Mellitus

Triamcinolone acetonide 40 mg

Phase 3

Acute Gout

Telbivudine (LdT)

Phase 3

Chronic Hepatitis B

VAY736

Phase 3

Sjogren Syndrome

Certican

Phase 3

Kidney Transplantation

Vildagliptin AM

Phase 3

Diabetes Mellitus, Type 2

terbinafine

Phase 3

Onychomycosis

Monovalent A/H1N1 influenza vaccine

Phase 3

Pandemic Influenza

CTL019

Phase 3

Acute Lymphoblastic Leukemia

imatinib mesylate

Phase 3

Leukemia

deferasirox

Phase 3

Non-transfusion Dependent Thalassemia

Ranibizumab 0.5 mg

Phase 3

Proliferative Diabetic Retinopathy (PDR)

telbivudine

Phase 3

Chronic Hepatitis B

Meningococcal C Conjugate Vaccine

Phase 3

Prevention of Meningococcal Infection

RLX030

Phase 3

Acute Heart Failure

secukinumab (AIN457)

Phase 3

Rheumatoid Arthritis

Ianalumab

Phase 3

Primary Immune Thrombocytopenia (ITP)

Olmesartan medoxomil

Phase 3

Hypertension

Tacrolimus

Phase 3

Kidney Diseases

trivalent split influenza vaccine

Phase 3

Seasonal Influenza

Focalin XR

Phase 3

ADHD

Everolimus + reduced tacrolimus

Phase 3

Liver Transplantation

Octreotide

Phase 3

Acromegaly

Pelacarsen

Phase 3

Atherosclerotic Cardiovascular Disease (ASCVD)

rMenB+OMV

Phase 3

Meningococcal Disease

Lamivudine

Phase 3

Chronic Hepatitis B

ciclosporin

Phase 3

Severe Atopic Dermatitis

Enteric-Coated Mycophenolate Sodium

Phase 3

Prevention of Acute Rejection After Kidney Transplantation

Pazopanib

Phase 3

Ovarian Cancer

Pimecrolimus

Phase 3

Keratoconjunctivitis Sicca

MenACWY-CRM

Phase 3

Meningococcal Disease

LCQ908

Phase 3

Familial Chylomicronemia Syndrome (FCS)

Imatinib

Phase 3

Chronic Myelogenous Leukemia in Chronic Phase

Darifenacin

Phase 3

Overactive Bladder Syndrome

Vatalanib

Phase 3

Colorectal Neoplasms

Serogroup B meningococcal vaccine

Phase 3

Meningococcal Disease

rivastigmine transdermal patch

Phase 3

Alzheimer's Disease

Pasireotide

Phase 3

Cushing's Disease

Indacaterol 150 μg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Myfortic

Phase 3

Kidney Transplantation

Umeclidinium/vilanterol

Phase 3

Chronic Obstructive Pulmonary Disease

Octreotide LAR

Phase 3

Acromegaly

Agomelatine (AGO178C)

Phase 3

Major Depressive Disorder

osilodrostat

Phase 3

Cushings Disease

Ofatumumab

Phase 3

Relapsing Multiple Sclerosis

Letrozole

Phase 3

Breast Cancer

LCZ696

Phase 3

Hypertension

Bortezomib

Phase 3

Multiple Myeloma

Meningococcal ACWY conjugate vaccine

Phase 3

Bacterial Meningitis

Fingolimod 1.25 mg

Phase 3

Multiple Sclerosis

Physicians' Choice

Phase 3

Leukaemia

ranibizumab 0.5mg

Phase 3

Choroidal Neovascularisation

Olmesartan

Phase 3

Essential Hypertension

Siponimod

Phase 3

Multiple Sclerosis (MS)

oxcarbazepine

Phase 3

Epilepsy

RTH258/Brolucizumab

Phase 3

Neovascular Age Related Macular Degeneration

Adalimumab

Phase 3

Psoriatic Arthritis

Diclofenac sodium gel 1%

Phase 3

Osteoarthritis

zigakibart

Phase 3

Kidney Diseases

Ranibizumab (RFB002)

Phase 3

Diabetic Macular Edema

Dabrafenib

Phase 3

Neoplasms, Brain

Indacaterol 150 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

valsartan + amlodipine

Phase 3

Hypertension

Ustekinumab

Phase 3

Psoriatic Arthritis

Gliclazide

Phase 3

Diabetes Mellitus, Type 2

Secukinumab 300 mg

Phase 3

Chronic Scalp Psoriasis

Salmeterol 50 μg

Phase 3

Chronic Obstructive Pulmonary Disease

AIN457

Phase 3

Plaque-type Psoriasis

goserelin

Phase 3

Advanced Metastatic Breast Cancer

Valsartan/amlodipine 80/5 mg

Phase 3

Hypertension

iptacopan

Phase 3

IC-MPGN

rMenB+OMV NZ

Phase 3

Prevention of the Meningococcal Disease

Brolucizumab

Phase 3

Diabetic Macular Edema

Seasonal Influenza Vaccine

Phase 3

Influenza

valsartan/amlodipine

Phase 3

Hypertension

Panobinostat

Phase 3

Cutaneous T-Cell Lymphoma

Tiotropium 18 μg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Fluvastatin

Phase 3

Mixed Dyslipidemia

Inclisiran sodium 300 mg

Phase 3

Atherosclerotic Cardiovascular Disease

Haemophilus influenzae type b (Hib) vaccine

Phase 3

Haemophilus Influenzae Type b (Hib) Infection

NIS793

Phase 3

Metastatic Pancreatic Ductal Adenocarcinoma

Hydrochlorothiazide

Phase 3

Hypertension

Verteporfin Photodynamic Therapy

Phase 3

Macular Degeneration

MenACWY-CRM197

Phase 3

Meningitis

vildagliptin + metformin

Phase 3

Diabetes Mellitus, Type 2

Basiliximab

Phase 3

Liver Transplant

Indacaterol 300 µg

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

BION-1301

Phase 3

IgA Nephropathy

LNP023

Phase 3

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Ruxolitinib

Phase 3

Cytokine Storm (Covid-19)

Ligelizumab

Phase 3

Chronic Spontaneous Urticaria

AMN107

Phase 3

Leukemia, Myeloid, Chronic

QAB149

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

Tobramycin inhalation powder

Phase 3

Pulmonary Infections

LOU064

Phase 3

Chronic Spontaneous Urticaria

MF59-eH1N1_f

Phase 3

Influenza

Glycopyrronium bromide

Phase 3

Chronic Obstructive Pulmonary Disease

Fingolimod

Phase 3

Multiple Sclerosis

dovitinib

Phase 3

Solid Tumors

Adjuvanted cell-derived, inactivated novel swine origin A/H1N1 monovalent subunit influenza virus vaccine

Phase 3

Swine-Origin Influenza A H1N1 Virus

Influenza virus vaccine

Phase 3

Influenza

Enalapril

Phase 3

Hypertension

Paclitaxel

Phase 3

Breast Cancer

secukinumab 150 mg

Phase 3

Moderate to Severe Chronic Plaque-type Psoriasis

Rivastigmine

Phase 3

Vascular Dementia

Sitagliptin

Phase 3

Diabetes Mellitus, Type 2

Indacaterol 300 μg

Phase 3

Chronic Obstructive Pulmonary Disease

Formoterol

Phase 3

Chronic Obstructive Pulmonary Disease

Mycophenolate mofetil (MMF)

Phase 3

Kidney Transplantation

Secukinumab (75 mg)

Phase 3

Psoriatic Arthritis

Remibrutinib

Phase 3

Chronic Spontaneous Urticaria

Formoterol (12 µg b.i.d.)

Phase 3

Pulmonary Disease, Chronic Obstructive

Nilotinib (AMN107)

Phase 3

Gastrointestinal Stromal Tumor (GIST)

NVA237

Phase 3

Chronic Obstructive Pulmonary Disease

Prednisone

Phase 3

Renal Transplantation

Remibrutinib Dose A

Phase 3

Hidradenitis Suppurativa

Hydrochlorothiazide (HCTZ)

Phase 3

Essential Hypertension

Lapatinib

Phase 3

Breast Neoplasms

LCZ696 (Sacubitril/Valsartan)

Phase 3

Chronic Heart Failure With Reduced Ejection Fraction

Exemestane

Phase 3

Breast Cancer

QVA149

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

vildagliptin

Phase 3

Diabetes Mellitus, Type 2

ranibizumab

Phase 3

Neovascular Age-related Macular Degeneration

TIVc

Phase 3

Influenza

Omalizumab

Phase 3

Asthma

QVM149

Phase 3

Asthma

secukinumab

Phase 3

Juvenile Psoriatic Arthritis

Tegaserod

Phase 3

Dyspepsia

Tisagenlecleucel

Phase 3

Follicular Lymphoma (FL)

aliskiren

Phase 3

Hypertension

Indacaterol

Phase 3

Asthma

Zoledronic acid

Phase 3

Breast Cancer With Bone Metastasis

Tiotropium

Phase 3

Chronic Obstructive Pulmonary Disease (COPD)

ramipril

Phase 3

Heart Failure

inclisiran sodium

Phase 3

Hypercholesterolemia

Tamoxifen

Phase 3

Hormone Sensitive Resected Primary Breast Cancer in Postmenopausal Women

Anastrozole

Phase 3

Breast Cancer

Mycophenolate sodium (enteric coated)

Phase 3

Renal Transplant

capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg)

Phase 3

Parkinson's Disease

Canakinumab pre-filled syringe

Phase 3

Acute Gouty Arthritis

amlodipine

Phase 3

Hypertension

Sunitinib

Phase 3

Carcinoma, Renal Cell

Diclofenac topical sodium gel 1%

Phase 3

Osteoarthritis

Pelabresib

Phase 3

Myelofibrosis

Ribociclib

Phase 3

Breast Cancer

sacubitril/valsartan

Phase 3

Heart Failure

TQJ230

Phase 3

Cardiovascular Disease and Lipoprotein(a)

valsartan plus hydrochlorothiazide

Phase 3

Hypertension

Trametinib

Phase 3

Melanoma and Brain Metastases

Pasireotide LAR

Phase 3

Acromegaly

RAD001

Phase 3

Carcinoma

QAW039

Phase 3

Asthma

Lumiracoxib

Phase 3

Knee Osteoarthritis

Licarbazepine

Phase 3

Bipolar Disorder

Onasemnogene Abeparvovec-xioi

Phase 3

Spinal Muscular Atrophy Type I

Canakinumab

Phase 3

Rheumatoid Arthritis

Enteric-coated Mycophenolate sodium (EC-MPS)

Phase 3

Liver Transplantation

Artemether-lumefantrine

Phase 3

Plasmodium Falciparum Malaria

Pelacarsen (TQJ230)

Phase 3

Cardiovascular Disease and Lipoprotein(a)

Valsartan

Phase 3

Hypertension

Nilotinib

Phase 3

Chronic Myelogenous Leukemia

FTY720

Phase 3

Multiple Sclerosis

pioglitazone

Phase 3

Diabetes Mellitus, Type 2

Fulvestrant

Phase 3

Breast Cancer

eltrombopag

Phase 3

Immune Thrombocytopenic Purpura (ITP)

Erenumab

Phase 3

Episodic Migraine

Metformin

Phase 3

Diabetes Mellitus, Type 2

agomelatine

Phase 3

Major Depressive Disorder (MDD)

Diclofenac Sodium

Phase 3

Acute Ankle Sprain

Salmeterol

Phase 3

Asthma

Investigator choice of chemotherapy

Phase 2

Nasopharyngeal Carcinoma

Sandostatin LAR Depot

Phase 2

Primary Insulin Hypersecretion

LFG316

Phase 2

Neovascular Age-elated Macular Degeneration (Wet AMD)

BGG492

Phase 2

Adrenocortical Adenoma

inhaled corticosteroid therapy

Phase 2

Bronchial Asthma

TIV

Phase 2

Human Influenza

Dovitinib (TKI258)

Phase 2

Gastrointestinal Stromal Tumors

H5N1 influenza vaccine

Phase 2

Avian Influenza

rMenB

Phase 2

Meningococcal Disease

Midostaurin

Phase 2

Acute Myeloid Leukemia

AHU377

Phase 2

Systolic Hypertension

Iptacopan (LNP023)

Phase 2

Age-Related Macular Degeneration

Investigational Treatment

Phase 2

Actinic Keratosis

BYM338

Phase 2

Sporadic Inclusion Body Myositis

CJM112

Phase 2

Asthma

AIN457A

Phase 2

Psoriatic Arthritis

Crizanlizuamb

Phase 2

Sickle Cell Disease (SCD)

CFZ533

Phase 2

Sjögren Syndrome

PDR001

Phase 2

Small Cell Lung Cancer

Nidufexor

Phase 2

Diabetic Nephropathy

VHB937

Phase 2

Alzheimer's Disease

DNK333 5 mg

Phase 2

Pruritus in Patients With Atopic Dermatitis

ECMPS-IEM

Phase 2

Detection Accuracy

bimagrumab

Phase 2

Muscle Wasting (Atrophy) After Hip Fracture Surgery

SBR759

Phase 2

Chronic Kidney Disease

Investigational new drug, company code: BGG492

Phase 2

Seizures

QBW251

Phase 2

Chronic Obstructive Pulmonary Disease, COPD

Surface Antigen, Inactivated, Influenza (form.2006-07)

Phase 2

Influenza

LYS006 20 mg

Phase 2

Inflammatory Acne

Adjuvanted H5N1 pandemic influenza vaccine

Phase 2

Pandemic H5N1 Influenza

AEE788

Phase 2

Glioblastoma Multiforme

indacaterol/glycopyrrolate

Phase 2

Chronic Obstructive Pulmonary Disease (COPD)

BKM120

Phase 2

HER2-positive Newly Diagnosed, Primary Breast Cancer

Capmatinib

Phase 2

Non-Small Cell Lung Cancer (NSCLC)

SAF312

Phase 2

Chronic Ocular Pain

Clozapine

Phase 2

Schizophrenia

Deferasirox (ICL670)

Phase 2

Iron Overload

prednisolone

Phase 2

Healthy

QMF149

Phase 2

COPD

Cyclosporine

Phase 2

Severe Aplastic Anemia

GIA632

Phase 2

Non-segmental Vitiligo

Adjuvanted influenza vaccine

Phase 2

Influenza Disease

BAF312

Phase 2

Relapsing Remitting Multiple Sclerosis

Trivalent influenza virus vaccine (TIV)

Phase 2

Human Influenza

Patupilone

Phase 2

Hepatocellular Carcinoma

LDK378

Phase 2

Non-Small-Cell Lung Cancer

Montelukast

Phase 2

Allergic Rhinitis

DJI136

Phase 2

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

MAS825

Phase 2

Coronary Heart Disease

Serelaxin

Phase 2

Acute Heart Failure

MCS110

Phase 2

Triple Negative Breast Cancer

influenza vaccine

Phase 2

Influenza

TOUR006 - 50 MG

Phase 2

Chronic Kidney Diseases

LIK066

Phase 2

Polycystic Ovary Syndrome

LEE011

Phase 2

Tumors With CDK4/6 Pathway Activation

CMK389

Phase 2

Pulmonary Sarcoidosis

LCI699

Phase 2

Hypertension

AQW051

Phase 2

Schizophrenia

crizanlizumab

Phase 2

Sickle Cell Disease (SCD)

KAF156

Phase 2

Malaria

DFV890

Phase 2

Symptomatic Knee Osteoarthritis

TCH346

Phase 2

Amyotrophic Lateral Sclerosis

LYS006

Phase 2

Hidradenitis Suppurativa

Bendamustine

Phase 2

Chronic Lymphocytic Leukemia (CLL)

QAX576

Phase 2

Allergic Rhinitis

DNK333

Phase 2

Irritable Bowel Syndrome

Cryptosporidium parvum oocysts (ABO809)

Phase 2

Cryptosporidiosis

Mometasone furoate

Phase 2

Asthma

HSC835

Phase 2

Single Umbilical Cord Blood Transplantation

AF056

Phase 2

Fragile X Syndrome

LHW090

Phase 2

Chronic Kidney Disease (CKD)

Seasonal flu vaccine

Phase 2

Seasonal Influenza

LDE225

Phase 2

Medulloblastoma

Aliskiren 300 mg

Phase 2

Post Acute Coronary Syndrome

AEB071

Phase 2

Kidney Transplantation

rapcabtagene autoleucel

Phase 2

Lupus Erythematosus, Systemic

cetuximab

Phase 2

KRAS G12C Mutant Solid Tumors

Atrasentan

Phase 2

IgA Nephropathy

CDZ173

Phase 2

Primary Sjögren's Syndrome

AFQ056

Phase 2

Dyskinesias

AAE581

Phase 2

Osteoporosis

Monovalent inactivated influenza vaccine

Phase 2

Prepandemic Influenza Vaccine

TIN816 70 mg lyophilisate powder

Phase 2

Acute Kidney Injury Due to Sepsis

Triamcinolone acetonide

Phase 2

Acute Gout

epothilone b

Phase 2

Colorectal Neoplasms

Tacrolimus (Tac)

Phase 2

Kidney Transplantation

Spartalizumab

Phase 2

Advanced Hepatocellular Carcinoma

PKN605

Phase 2

Atrial Fibrillation

JDQ443

Phase 2

Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation

rapcabtagene autoleucel (YTB323)

Phase 2

Relapsing Multiple Sclerosis

dexamethasone

Phase 2

Arthritis, Gouty

INC424

Phase 2

Primary Myelofibrosis

YTB323

Phase 2

Systemic Lupus Erythematosus

AUY922

Phase 2

Relapsed or Refractory Multiple Myeloma

TOUR006 - 20 MG

Phase 2

Thyroid Eye Disease

[177Lu]Lu-PSMA-617

Phase 2

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Capecitabine

Phase 2

Breast Cancer

ICL670

Phase 2

Sickle Cell Disease

Vinorelbine

Phase 2

Cancer

LAG525

Phase 2

Melanoma

Eltrombopag 12.5 mg

Phase 2

Cytopaenia

LDE225 0.25%

Phase 2

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

fluticasone propionate/salmeterol

Phase 2

Asthma

TKI258

Phase 2

Melanoma

QGE031

Phase 2

Asthma

N-acetylcysteine

Phase 2

Common Cold Associated With Cough

CAD106

Phase 2

Alzheimer Disease

KAE609

Phase 2

Malaria

buparlisib

Phase 2

Breast Cancer

📑
Catalyst DossierPRO
The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.
→
Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move
Regulatory Approvals

Frequently asked questions

What is in NOVARTIS AG's drug pipeline?→

CatalystAlert tracks 294 drug candidates in NOVARTIS AG's (NVSEF) pipeline across Phase 3, Phase 2. Its lead program is Bosutinib (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is NOVARTIS AG's next FDA catalyst?→

NOVARTIS AG's (NVSEF) next tracked catalyst is a Phase 2 expected September 15, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track NVSEF biotech catalysts?→

Add NVSEF to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NOVARTIS AG's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply